Senate dispute expected as FDA nominee passes committee

Senate dispute expected as FDA nominee passes committee

[JURIST] A Senate committee approved the nomination of Lester Crawford [official profile] as the new head of the US Food and Drug Administration [official site] on Wednesday, sending the issue to the full Senate for a final vote. A number of Democrats on the committee had criticized Crawford, currently acting FDA Commissioner, for not having made a determination on allowing over-the-counter sales of emergency contraceptives [Reuters report] and say they will try and block a floor vote. Sen. Tom Coburn (R-OK) [official site] also wants to put a full vote on hold until another birth control issue, condom labeling, is decided. Reuters has more.